1. Home
  2. PRPO vs BEAT Comparison

PRPO vs BEAT Comparison

Compare PRPO & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$28.51

Market Cap

44.4M

Sector

Industrials

ML Signal

N/A

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$0.92

Market Cap

44.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPO
BEAT
Founded
N/A
2015
Country
United States
United States
Employees
N/A
16
Industry
Biotechnology: Laboratory Analytical Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
44.4M
44.8M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
PRPO
BEAT
Price
$28.51
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
15.5K
1.4M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
92.15
N/A
EPS
N/A
N/A
Revenue
$24,049,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$315.97
P/E Ratio
N/A
N/A
Revenue Growth
29.77
N/A
52 Week Low
$6.78
$0.54
52 Week High
$33.63
$4.00

Technical Indicators

Market Signals
Indicator
PRPO
BEAT
Relative Strength Index (RSI) 48.27 49.19
Support Level $25.95 $0.91
Resistance Level $29.66 $1.26
Average True Range (ATR) 2.29 0.05
MACD -0.26 0.02
Stochastic Oscillator 29.53 91.21

Price Performance

Historical Comparison
PRPO
BEAT

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Share on Social Networks: